<img height="1" width="1" style="display:none" src="https://q.quora.com/_/ad/1103c3a45d2e46399d3d99b48950095f/pixel?tag=ViewContent&amp;noscript=1">

Nova Health Tech Startup Programme | Applications Open Until 31st Oct | Learn More

Realise _

Your Ambition.

Growing your good idea into a great startup


Partnering with Nova gives your startup a 5 times greater chance of success

We have cofounded over 40 tech startups in the past 5 years

View startupsOur process


Working with our experienced team and process, we will guide your startup from:






Learn more about our


Support and Guidance

Team and resource


Find out more

Start your journey today by applying for our tech startup programme

Investments of this nature carry risks to your capital. The risks include illiquidity where shares may not be able to be sold easily, lack of dividends and dilution. Past performance is not indicative of future returns. Investors should only invest a proportion of their available investment funds into Nova Cofoundery SEIS & EIS Fund as these investments are high risk.

The availability of any tax relief, including EIS and SEIS, depends on the individual circumstances of each investor and of the company concerned, is only available for UK investors in qualifying companies and may be subject to change in the future. If you are in any doubt about the availability of any tax reliefs, or the tax treatment of your investment, you should obtain independent tax advice before proceeding with your investment.

Nova Growth Capital Limited is an Appointed Representative of Sapphire Capital Partners LLP, which is authorised and regulated by the Financial Conduct Authority (FRN 565716).